Page-2 of USFDA
FDA approves Convalescent Plasma Treatment for seriously ill COVID-19 patients
The Food and Drug Administration of the United States has approved the use of Convalescent plasma collected from patients recovered from COVID-19 to treat seriously ill COVID-19 patients. The idea of the method is to inject plasma with antibodies into ..
Month: Current Affairs - March, 2020
President Trump visit to India: 2 MoUs and 1 Letter of Cooperation signed
On February 24, 2020, the US President Donald Trump visited India along with his wife Melania Trump. On the sidelines of his visit, agreements were signed in the field of health, oil and defence. Highlights In the Defence Sector, 3 ..
Month: Current Affairs - February, 2020
BioAsia Summit 2020 to be held in Hyderabad
The Government of Telangana is hosting Bio-Asia Summit 2020 in Hyderabad between February 17, 2020 and February 19, 2020. The main objective of the summit is to explore the capabilities of Life Science Companies and their investments. Highlights The summit ..
Month: Current Affairs - February, 2020
CSIR Nuclear Magnetic Resonance Test gets US FDA certification
The CSIR-IICT, Hyderabad on December 3, 2019, announced that the US Food and Drug Administration (USFDA) cleared the Nuclear Magnetic Resonance (NMR) Test facility at the centre. The inspection was conducted between August 21, 2019 and August 22, 2019 with ..
Month: Current Affairs - December, 2019
USFDA approves world’s first contact lens that automatically darkens when exposed to bright light
The US Food and Drug Administration (FDA) has approved use of Acuvue Oasys Contact Lenses with Transitions Light Intelligent Technology, world’s first contact lens that automatically darkens when exposed to bright light. It is first of its kind contact lens ..
Month: Current Affairs - April, 2018
US FDA hikes fee for generic drug approvals
United state Food and Drugs Administration (USFDA) has hiked its fees by 30 percent for new generic drug applications. Earlier the fee for Abbreviated New Drug Applications (ANDAs) was 58,730 dollars and now has risen by 30 per cent to 76,030 ..
Month: Current Affairs - August, 2015
USFDA approves first anti-epilepsy pill manufactured with 3D printer
Aprecia’s Spritam becomes first anti-epilepsy pill manufactured with 3D printer to get the US Food and Drug Administration (USFDA) approval. The specified porous structure of the pill ‘Spritam’ was developed by using ZipDose 3D printing technology by Aprecia Pharmaceuticals. Designing detail ..